Legal and compliance teams have to serve as sentinels sizing up potential legal exposure points without turning into needlers who only slow down clinical innovation. Legal and compliance teams have to serve as sentinels sizing up potential legal exposure points without turning into needlers who only slow down clinical innovation. | | |
|
The agency said it is seeking to exclude semaglutide, tirzepatide and liraglutide from the 503B program based on a lack of clinical evidence. Unless there’s a shortage, the pharmaceuticals would be barred from being compounded by third-parties for the purpose of treating diabetes or obesity. The FDA is seeking public comment on the proposal. The agency said it is seeking to exclude semaglutide, tirzepatide and liraglutide from the 503B program based on a lack of clinical evidence. Unless there’s a shortage, the pharmaceuticals would be barred from being compounded by third-parties for the purpose of treating diabetes or obesity. The FDA is seeking public comment on the proposal. | | |
|
Some Omnipod 5 devices, manufactured by Insulet, are subject to the Class I recall. The products with the defect must be removed from where they are used or sold to ensure safety, as lower-than-expected insulin doses could have potentially lethal repercussions. Some Omnipod 5 devices, manufactured by Insulet, are subject to the Class I recall. The products with the defect must be removed from where they are used or sold to ensure safety, as lower-than-expected insulin doses could have potentially lethal repercussions. | | |
|
U.S. healthcare is in the throes of an affordability crisis. The good news is that healthcare leaders have all the evidence, tools and expertise needed to keep the predicament from becoming a plight. Can they marshal the will to wield those weapons toward that end? U.S. healthcare is in the throes of an affordability crisis. The good news is that healthcare leaders have all the evidence, tools and expertise needed to keep the predicament from becoming a plight. Can they marshal the will to wield those weapons toward that end? | | |
|
|
Certain corners of the healthcare AI industry continue hyping the notion that their technology will render physicians unneeded. Young people, including potential medical students, might believe the claim. Here’s help. Certain corners of the healthcare AI industry continue hyping the notion that their technology will render physicians unneeded. Young people, including potential medical students, might believe the claim. Here’s help. | | |
|
Check Point Research revealed in a new report that VECT 2.0—advertised as a powerful, secure ransomware service—contains a fatal coding error that wipes victims’ data instead of encrypting it. Check Point Research revealed in a new report that VECT 2.0—advertised as a powerful, secure ransomware service—contains a fatal coding error that wipes victims’ data instead of encrypting it. | | |
|
A handful of health-system CEOs took withering fire this week at a hearing of the House Ways and Means Committee. A handful of health-system CEOs took withering fire this week at a hearing of the House Ways and Means Committee. | | |
|
During the COVID-19 pandemic, telehealth provider HealthTap began to emphasize its ability to deliver primary care services. Now, Co-Founder and CEO Sean Mehra says, long-term patient care delivered from anywhere has become its central focus, as advancements in technology made it a reality. During the COVID-19 pandemic, telehealth provider HealthTap began to emphasize its ability to deliver primary care services. Now, Co-Founder and CEO Sean Mehra says, long-term patient care delivered from anywhere has become its central focus, as advancements in technology made it a reality. | | |
|
|
The maker of popular GLP-1 agonists Wegovy and Ozempic said technology from OpenAI, the company behind ChatGPT, will allow it to sift through and make sense of massive datasets to identify potential new uses for its diabetes and obesity treatments. The maker of popular GLP-1 agonists Wegovy and Ozempic said technology from OpenAI, the company behind ChatGPT, will allow it to sift through and make sense of massive datasets to identify potential new uses for its diabetes and obesity treatments. | | |
|
MGMA says Trump’s immigration policy combined with Congress’s unwillingness to fund additional medical residency positions is a primary driver accelerating the growing U.S. healthcare staffing shortage. MGMA says Trump’s immigration policy combined with Congress’s unwillingness to fund additional medical residency positions is a primary driver accelerating the growing U.S. healthcare staffing shortage. | | |
|
|
The move, once finalized, helps Johnson & Johnson add multiple FDA-approved technologies to its EP portfolio. The move, once finalized, helps Johnson & Johnson add multiple FDA-approved technologies to its EP portfolio. | | |
|
About 38% of rads surveyed said they had defended against at least one lawsuit, with such specialists at a higher risk than others in internal medicine. About 38% of rads surveyed said they had defended against at least one lawsuit, with such specialists at a higher risk than others in internal medicine. | | |
|
